Learn More
Enzo Life Sciences BML-275 (25mg). CAS: 866405-64-3

Supplier: Enzo Life Sciences BMLEI3690025
Cell-permeable pyrrazolopyrimidine derivative that inhibits AMP kinase (Ki=109nM in the absence of AMP) in an ATP-competitive manner. It displays no significant inhibition of ZAPK, SYK, PKCT, PKA and JAK3. Decreases food intake in mice and inhibits the effects of AICAR and metformin. It has been shown to inhibit BMP type I receptors ALK2, ALK3 and ALK6. Promotes cardiomyogenesis in mouse embryonic stem cells. Induces protective autophagy in cancer cell lines. Alternative name: Compound C, Dorsomorphin. Purity: ≥98% (TLC). Solubility: Soluble in DMSO (3mg/ml, warm). Long Term Storage: -20°C.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.